Finanzwire Finanzwire
Basculer en Français
9754 Companies
194889 Keywords
125909 Articles
103622 Press releases
Headlines Articles Press releases Simcere Pharmaceutical Group Limited Remove
  1. Home
  2. Companies
  3. Simcere Pharmaceutical Group Limited
Finanzwire
Basculer en Français
Headlines Articles Press releases

News

  • BRIEF

    published on 01/27/2026 at 12:00, 3 hours 46 minutes ago

    Boehringer Ingelheim and Simcere Collaborate on IBD Treatment

    Immunology Boehringer Ingelheim Inflammatory Bowel Disease Bispecific Antibody Simcere Partnership
  • PRESS RELEASE

    published on 01/27/2026 at 11:55, 3 hours 51 minutes ago

    Boehringer Ingelheim and Simcere partner to advance a dual-target antibody treatment to address unmet needs in inflammatory bowel disease

    Boehringer Ingelheim and Simcere partner to advance a dual-target antibody treatment for inflammatory bowel disease. SIM0709, a novel bispecific antibody, aims to improve outcomes for patients worldwide
    Boehringer Ingelheim Inflammatory Bowel Disease IBD Simcere Antibody Treatment
    Logo of Simcere Pharmaceutical Group Limited
Accesswire
  • Published on 01/27/2026 at 15:00, 46 minutes ago

    MicroVision Announces Agreement to Acquire Luminar Assets to Accelerate Commercial Strategy and Expand Product Portfolio

  • Published on 01/27/2026 at 14:45, 1 hour 1 minute ago

    Organto Announces Appointment of Chad Hagen to the Board of Directors

  • Published on 01/27/2026 at 14:30, 1 hour 16 minutes ago

    NV Gold Announces Non-Brokered Private Placement

  • Published on 01/27/2026 at 14:23, 1 hour 23 minutes ago

    Worksport Subsidiary Terravis Energy Selects Major Asian Manufacturing Partner for Breakthrough Zerofrost(TM) Heat Pump; Announces Path to Commercialization Within 2026

  • Published on 01/27/2026 at 14:15, 1 hour 31 minutes ago

    Terravis Energy Secures Mass Manufacturing for No-Defrost Heat Pump Amid North American Polar Vortex Crisis

View all ACCESSWIRE
EQS Group
  • Published on 01/27/2026 at 15:05, 41 minutes ago

    IBO International Expands Client Support with German-Language Analyst Sessions

  • Published on 01/27/2026 at 15:04, 42 minutes ago

    Statement by PUMA CEO Arthur Hoeld regarding the announcement by ANTA Sports Products Limited

  • Published on 01/27/2026 at 15:00, 46 minutes ago

    Amundi ETF ICAV: NOTICE TO SHAREHOLDERS

  • Published on 01/27/2026 at 15:00, 46 minutes ago

    The NAGA Group Reports Preliminary FY2025 Results on 12 February 2026 – Invitation to Earnings Webcast/Call on the Same Day

  • Published on 01/27/2026 at 14:50, 56 minutes ago

    Alektum Group rebrands as Myntro - First company in the EU to obtain SDR status

View all EQS
Les Echos
  • Published on 01/27/2026 at 14:05, 1 hour 41 minutes ago

    Notice of exercise of early redemption option of the subordinated note ISIN : FR0010167296

  • Published on 01/27/2026 at 14:01, 1 hour 45 minutes ago

    Notice of exercise of early redemption option of the subordinated note ISIN : FR0010167247

  • Published on 01/27/2026 at 12:44, 3 hours 2 minutes ago

    Statement of transactions in own shares from January 19, 2026 to January 23, 2026

  • Published on 01/27/2026 at 08:00, 7 hours 46 minutes ago

    LDC : The UK Competition and Markets Authority (CMA), the competition regulatory authority in the United Kingdom, has notified LDC of the opening of a review procedure in relation to the acquisition of shares in Green Label Holdings Ltd.

  • Published on 01/27/2026 at 07:46, 8 hours ago

    OPmobility signs with Hyundai Mobis a Memorandum of Understanding to explore a potential acquisition of its lighting business

View all LES ECHOS COMFI WIRE

With finanzwire.com, you can follow all the latest financial news in real time from the best sources for companies listed on the Paris, Brussels, Amsterdam, Lisbon, Frankfurt and New York stock exchanges. You'll have access to summary articles written by us and press releases published by the companies themselves.

Finanzwire

87, rue Ordener - 75018 Paris

Contact us

+33 1 42 23 83 61

© 2026 Finanzwire

Contact Authors Cookies policy Terms and conditions Privacy policy